Non-Invasive Detection of Fibrotic NASH in NAFLD Patients with Low or Intermediate FIB-4.
Katharina JohnMartin FranckSherin Al AouaMonika RauYvonne HuberJörn Markus SchattenbergAndreas GeierMatthias J BahrHeiner WedemeyerKlaus Schulze-OsthoffHeike BantelPublished in: Journal of clinical medicine (2022)
The combination of FIB-4 with M30 enables a more reliable identification of patients at risk for progressed NAFLD and might, therefore, improve patient stratification.